Roflumilast Tablets (VA-27-00006601)
Archived on October 17, 2026. Original response deadline: . Full description on SAM.gov.
Overview
- Response deadline
- 2:30 PM CDT
- Posted
- September 9, 2026
- Notice type
- Sources Sought
- Set-aside
- No Set aside used
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Office
- NAC PHARMACEUTICALS (36E797)
- Last updated
- Oct 28, 2026
- First published
- Last updated on SAM.gov
Identifiers
- Solicitation number
- 36E79726Q0005
- Notice ID
- 56fa1cf0b4c9407183f5a9b8418504c8
Description
I am conducting market research for the procurement of Roflumilast Tablets, for the Department of Veterans Affairs (VA), Department of Defense (DoD), Indian Health Service (IHS), Bureau of Prisons (BOP), and Federal Health Care Center (FHCC). This procurement will result in national mandatory requirements contract for the above agencies. Other companies with the same/similar product will be blocked out for ordering; therefore it is our goal to award lower than FSS/Open Market prices on the resultant national contract based on purchases of a committed volume. These products will be awarded in the aggregate for all strengths and sizes for the base year and all option years included in the solicitation. Please provide a response to the following:
- Is your Company able to meet the following minimum requirements:
- National Drug Code (NDC): Offerors shall provide a separate and distinct eleven-digit NDC number unique to the offeror (e.g., 00012-3456-78) for each product proposed. The first five numbers of the eleven-digit NDC number for each product proposed shall identify the offeror. Additionally, the successful offeror/contractor’s label with its unique NDC shall be the only label on the product. Contractors shall not affix their label over another label on the product. Does your company have a unique NDC (Labeler Code)?_____________
- If the offeror is not the manufacturer of the offered items, the offeror shall submit a letter of commitment from the manufacturer to the offeror which will assure the offeror a source of supply sufficient to satisfy the Government's requirements for the contract period. Name of Manufacturer: _________________
Would you be able to provide a letter of commitment from the manufacturer of the offered drug? _____________
- Pharmaceutical Prime Vendor: All Ordering Activities under the Department of Veterans Affairs and Department of Defense acquire their pharmaceutical requirements through their Pharmaceutical Prime Vendor Program (PPV). The contractor shall ensure that chargeback agreements with the PPVs have been executed with sufficient time to permit the PPVs to begin timely distribution of Government orders, if an award is made. Does your company currently have a business-to-business agreement with the PPVs?_________
- Under NAICS code 325412, is your company size (check one):
Large Business ______
Small Business ______
- If a small business, does your company manufacture (measure, weigh, mix, and compound) at least 50% of the product offered?_________
- Is the offered end product U.S-made or an end product of a Trade Agreements Act designated country?_________
- Can your company meet the following product, bottle size and usage? Please indicate any details or comments.
___________________________________________________________
___________________________________________________________
Award Overview
No prior contract identified
No prior award matched this notice's agency, NAICS, place of performance and PSC within 18 months. It may be a new requirement.
Contacts
Contracting Officer
Primary Contact
Documents
Files (1)
- Download
36E79726Q0005 RFI mod.docx
28 KBAdded in Sources Sought version 3Posted
Lifecycle
- 3Version 3Sources SoughtArchivedCurrent
Roflumilast Tablets (VA-27-00006601)
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79726Q0005
Archive Date
Oct 17, 2026
Office Address
HINES, IL, 60141